When Should We Biopsy? A Risk Factor-Based Predictive Model for EIN and Endometrial Cancer
This six-factor clinical model stratifies individual EIN/EC risk using readily available variables and may guide timely, risk-based biopsy decisions by identifying high-risk patients while minimizing unnecessary procedures in low-risk cases. BMI ≥ 30 kg/m<sup>2</sup> (WHO obesity threshold) was confirmed as a meaningful cutoff, but external validation is warranted to confirm its generalizability and clinical applicability.
Authors
- Shina Jang (ORCID: https://orcid.org/0000-0003-0010-4144)
- Sung Ook Hwang
Institutions
- Inha University Hospital (KR)
Publication Details
- Journal
- Cancers
- Published
- 2025-11-27
- DOI
- https://doi.org/10.3390/cancers17233809
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00